Results
Kwality Pharma Raises FY27 Revenue and Profit Guidance
Kwality Pharma raised its FY27 revenue guidance to INR 700+ Cr (+39%+ YoY) and PAT guidance to INR 109+ Cr (+220 bps margin) on strong execution.
The company is constructing a dedicated hormone plant
